EP3766986
DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS
Zusammenfassung
[0001] This disclosure provides, among other things, methods for generating and applying therapeutic interventions. The methods involve, for example, (a) sequencing polynucleotides from cancer cells from a subject; (b) identifying and quantifying somatic mutations in the polynucleotides; (c) developing a profile of tumor heterogeneity in the subject indicating the presence and relative quantity of a plurality of the somatic mutations in the polynucleotides, wherein different relative quantities indicates tumor heterogeneity; and (d) determining a therapeutic intervention for a cancer exhibiting the tumor heterogeneity, wherein the therapeutic intervention is effective against a cancer having the profile of tumor heterogeneity determined.
Anmelder
GUARDANT HEALTH INC [US]
Erfinder
ELTOUKHY HELMY [US]TALASAZ AMIRALI [US]KERMANI BAHRAM GHAFFARZADEH [US]IHUEGBU NNAMDI [US]
Externe Quellen
Klassifikation
IPC-Klassen
C12N 15/11C12Q 1/68C12Q 1/6869G16B 30/00
CPC-Klassen
C12N 15/11C12Q 1/6827C12Q 1/6869C12Q 1/6886G16B 30/00
AI: Life Sciences
warum
Guardant Health tumor-heterogeneity diagnostics — C12N + C12Q + G16B. Life Science.